Atsena Therapeutics is a gene therapy company that is developing novel therapies for inherited degenerative retinal diseases with no other treatment alternatives. Atsena was founded based on the research of Dr. Shannon Boye and Dr. Sanford Boye at University of Florida, who are pioneers in the field of ophthalmology gene therapy. The company is also in-licensing a clinical stage gene therapy program from a large pharmaceutical company that was previously developed in Dr. Boye’s lab and subsequently licensed.